Hot Flash. Menopausal and female climacteric states
Conditions
Interventions
Intervention 1: Intervention group: Escitalopram tab 10mg one time a day for 4 weeks. Intervention 2: control group:Placebo tab one time a day for 4 weeks. Intervention 3: Intervention group: relaxati
Treatment - Drugs
Placebo
Behavior
Intervention group: Escitalopram tab 10mg one time a day for 4 weeks
Intervention group: relaxation methods at least 30 minutes one time a day for 4 weeks
Sponsors
Vice chancellor for Research, Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: having at least 4 hot flash attacks daily; Age range is 18 to 65 years; a history of breast cancer; not in acute phase of breast cancer, Ability to read and write and being able to answer questions ;Consent to participate in the study; Not concurrent using of any drugs that affect hot flash symptoms such as gabapentin, pregabalin, clonidine, SSRIs, herbal drugs and other treatments such as acupuncture, hypnotism ; no Non-malignant hypertension or CVA or MI or other uncontrolled organic problems and psychotic or bipolar disorders Exclusion criteria: incidence of intolerable drug side effects, breast cancer relapse needing chemotherapy
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hotflash frequency. Timepoint: before treatment and 4 weeks after treatment. Method of measurement: Hotflash diary. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hotflash duration. Timepoint: before treatment and 4 weeks after treatment. Method of measurement: Hotflash diary. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Maryam Shirzadi
Kermanshah University Of Medical Science
Outcome results
None listed